It can reduce lipid oxidation in nerve tissue; it may prevent the glycosylation of proteins; it inhibits aldose reductase, prevents the conversion of glucose or galactose into sorbitol, prevents diabetes, controls blood sugar and prevents neuropathy caused by hyperglycemia; it is a strong antioxidant in both water-soluble and oil-soluble matrices; it can directly or indirectly promote the regeneration of vitamin C and vitamin E in the body; it can increase the levels of glutathione and coenzyme Q10 in cells; it can chelate certain metal ions (such as copper, manganese, zinc) to form stable chelates; it protects against arsenic poisoning and can reduce liver toxicity after chromium poisoning; it chelates mercury ions in kidney slices.

Hypoglycemic drugs. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, reducing liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take in glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low-density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low-density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the production of ketone bodies and promote the use of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

Inhibits liver glycogenolysis and glycogenoneogenesis, reduces liver output of glucose; promotes liver uptake of glucose and synthesis of liver glycogen; promotes muscle and adipose tissue uptake of glucose and amino acids, promotes the synthesis and storage of protein and fat; causes the liver to produce very low density lipoprotein and activates lipoprotein lipase, promotes the decomposition of very low density lipoprotein; inhibits the decomposition of fat and protein in fat and muscle, inhibits the production of ketone bodies and promotes the utilization of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

This product is a hypoglycemic drug. The main effect of insulin is to lower blood sugar, and it also affects protein and fat metabolism, including the following effects: 1. Inhibit liver glycogenolysis and gluconeogenesis, and reduce liver output of glucose; 2. Promote liver uptake of glucose and synthesis of liver glycogen; 3. Promote muscle and adipose tissue to take up glucose and amino acids, promote protein and fat synthesis and storage; 4. Make the liver produce very low density lipoprotein and activate lipoprotein lipase, promote the decomposition of very low density lipoprotein; 5. Inhibit the decomposition of fat and protein in fat and muscle, inhibit the generation of ketone bodies and promote the use of ketone bodies by surrounding tissues.

No specific pharmacological effects mentioned

This product is a monoquaternary ammonium steroid medium-acting non-depolarizing muscle relaxant, similar in structure to pancuronium bromide, which blocks the conduction between nerve endings and striated muscles by competing with acetylcholine for nicotinic receptors located at the motor end plate of striated muscles. Unlike depolarizing neuromuscular blocking drugs such as succinylcholine, this product does not cause muscle fiber bundles to tremble. Intravenous injection of 0.08-0.1mg/kg is effective within 1 minute, reaching a peak in 3-5 minutes, and maintaining for 30-90 minutes. The muscle relaxant effect is 3 times stronger than that of tubocurarine chloride; it has no vagus nerve blocking effect. Since vecuronium bromide does not cause an increase in heart rate, it is suitable for patients with myocardial ischemia and heart disease, but the use of vagus nerve excitants and β-receptor blockers is prone to bradycardia. This product has a weak histamine release effect, and there are also bronchospasm and allergic reactions, but they are rare.